Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

635
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
635
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

248
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
248
Dementia01:30

Dementia

158
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
158
Associative Learning01:27

Associative Learning

525
Associative learning is a fundamental concept in behavioral psychology, wherein a connection is established between two stimuli or events, leading to a learned response. This process is critical in understanding how behaviors are acquired and modified. Conditioning, the mechanism through which associations are formed, can be divided into two main types: classical conditioning and operant conditioning, each elucidating different aspects of associative learning.
Classical conditioning, also known...
525

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-immunocyte transcriptomics reveal the role of natural killer cell-dependent exogenous antigen presentation in ankylosing spondylitis severity.

Experimental & molecular medicine·2026
Same author

Cartilage organoids bridging bench to bedside: A steroid-free strategy for early osteoarthritis repair.

Materials today. Bio·2026
Same author

Esterified-pectin-coupled polar stiffening controls grass stomatal opening.

Nature plants·2026
Same author

Expression of concern: 3D-printed magnetic Fe<sub>3</sub>O<sub>4</sub>/MBG/PCL composite scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia.

Journal of materials chemistry. B·2026
Same author

Differential organ-specific toxicity profiling of BDE-209 and its derivative DBDPE in zebrafish.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Human peripheral osteoclast-precursor-development patterns reveal the significance of RPS17-dependent ribosome synthesis to Ankylosing Spondylitis lesions.

Bone research·2025

Related Experiment Video

Updated: Aug 26, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Multi-modal sequence learning for Alzheimer's disease progression prediction with incomplete variable-length

Lei Xu1, Hui Wu2, Chunming He3

  • 1School of Artificial Intelligence, Optics and Electronics (iOPEN), Northwestern Polytechnical University, Xi'an 710072, PR China; School of Computer Science, Nanjing University of Posts and Telecommunications, Nanjing 210023, PR China.

Medical Image Analysis
|October 8, 2022
PubMed
Summary

Predicting Alzheimer's disease (AD) progression is crucial for early diagnosis and care. This study introduces a flexible deep learning framework to handle incomplete patient data, improving AD progression prediction accuracy.

Keywords:
Alzheimer’s diseaseDisease progression predictionLatent representation learningMissing modalityMulti-modal learningSequence learning

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI&#8212;Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Related Experiment Videos

Last Updated: Aug 26, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI&#8212;Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Area of Science:

  • Neuroscience
  • Computational Biology
  • Medical Informatics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a lengthy preclinical phase.
  • Accurate prediction of AD progression is vital for timely diagnosis and patient management.
  • Existing prediction models often fail to accommodate variable patient data, including missing information and irregular visit schedules.

Purpose of the Study:

  • To develop a flexible framework for predicting Alzheimer's disease progression using longitudinal, multi-modal data.
  • To address challenges posed by modality-missing data and variable-length patient histories.
  • To improve the accuracy and applicability of Alzheimer's disease progression prediction models.

Main Methods:

  • A novel multi-modal sequence learning framework integrating deep latent representation and collaborative sequence learning.
  • A deep multi-modality fusion module to capture complementary information from incomplete datasets.
  • Collaborative training of fusion and sequence learning modules for enhanced prediction performance.

Main Results:

  • The proposed framework effectively handles incomplete, variable-length longitudinal multi-modal data.
  • Demonstrated superiority over existing methods in predicting Alzheimer's disease progression.
  • Validated on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.

Conclusions:

  • The developed deep learning framework offers a flexible and robust approach for Alzheimer's disease progression prediction.
  • This method can better manage real-world clinical data complexities, including missing modalities and irregular visits.
  • The findings support improved diagnostic and prognostic capabilities for Alzheimer's disease.